Advertisement

Topics

First Oncology Biosimilar Approved in US: Bevacizumab

09:18 EDT 14 Sep 2017 | Medscape

The FDA has approved the first biosimilar for use in the treatment of cancer: Myasi, or bevacizumab-awwb (equivalent to Avastin).
News Alerts

Original Article: First Oncology Biosimilar Approved in US: Bevacizumab

NEXT ARTICLE

More From BioPortfolio on "First Oncology Biosimilar Approved in US: Bevacizumab"

Quick Search
Advertisement
 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...